After the recent slump, Big Rock Partners Acquisition Corp (NASDAQ:BRPA) stock saw a big relief rally on Thursday’s trading session as it topped among the top percentage gainers.
The stock started almost flat and moved sideways till late morning. However, buyers kicked in by the afternoon session and the stock went up from $19.19 to as high as $48.80 – a whopping rally of 156%. However, by the closing, the stock saw some profit booking and closed higher by 88% at $36.08.
Despite today’s rally, the stock is still down 53% from its 52-week high of $77.
Recently the company’s SPAC merger target, NeuroRx, on Monday confirmed dosing of the first patient in a Phase 3 trial of ZYESAMI was announced by the NIH last week.
The trial, designated as ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19, will study ZYESAMI to treat severely ill COVID-19 patients.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.